Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01038Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories
BSE1733.40-9.85 (-0.57 %)
PREV CLOSE () 1743.25
OPEN PRICE () 1757.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12906
TODAY'S LOW / HIGH ()1716.60 1757.65
52 WK LOW / HIGH ()1058.7 1757.65
NSE1735.00-9.05 (-0.52 %)
PREV CLOSE() 1744.05
OPEN PRICE () 1744.05
BID PRICE (QTY) 1735.00 (105)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 499010
TODAY'S LOW / HIGH() 1715.80 1750.00
52 WK LOW / HIGH ()1052 1750
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1949

Management Info :

Premchand Godha - Chairman Pranay Godha - Managing Director

Registered Office :

Address : 48 , Kandivli Industrial Estate,Kandivli (West), ,
Mumbai,
Maharashtra-400067

Phone : 022- 66474444 / 62106050

Email : ipca@ipca.com

Website : www.ipca.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
03Jan IPCA Laboratories informs about change
IPCA Laboratories has informed that the Company has received communicati..
26Dec Ipca Laboratories informs about tradin
Ipca Laboratories has informed that the trading window for dealing in th..
05Dec Ipca Laboratories secures approval for
Ipca Laboratories has received necessary approval for voluntary closure..
15Nov Ipca Laboratories informs about newspa
Pursuant to Regulation 30 and Regulation 47 of the SEBI (Listing Obligat..
04Oct Ipca Laboratories informs about loss o
Ipca Laboratories has informed that the Company has issued duplicate sha..
Financials
in Millions
QTR Sep 24 ANNUAL 24
Net Profit2441.25304.1
Gross Profit 3392.1 8221.6
Operating Profit 4191.113226.7
Net Sales 18109.461664.6
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
RPG Life Sciences (BSE)
 2332.90 (5.99%)
M.Cap ( in Cr)
3858.39
Orchid Pharma (BSE)
 1982.80 (6.13%)
M.Cap ( in Cr)
10056.58
Wockhardt (BSE)
 1518.60 (5.04%)
M.Cap ( in Cr)
24673.05
Gland Pharma (BSE)
 1901.35 (3.19%)
M.Cap ( in Cr)
31325.07
Innova Captab (BSE)
 1180.25 (3.56%)
M.Cap ( in Cr)
6753.97
Shareholding Pattern
PROMOTERS 46.3%
MUTUAL FUNDS/UTI 28.55%
NON-INSTITUTION 8.65%
FI/BANKS/INSURANCE 4.87%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX79223.11-720.60 (-0.90%)
NIFTY24004.75-183.90 (-0.76%)
Dow Jones 42732.13339.86 (0.80%)
Nasdaq 19621.68340.89 (1.77%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI